Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Shares Issued (2018 - 2025)

Neurogene (NGNE) has disclosed Shares Issued for 5 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 1030.36% year-over-year to $9.7 million, compared with a TTM value of $9.8 million through Sep 2025, up 188.92%, and an annual FY2023 reading of $168000.0, changed N/A over the prior year.
  • Shares Issued was $9.7 million for Q3 2025 at Neurogene, up from $68000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $9.7 million in Q3 2025 and bottomed at -$1.0 million in Q3 2024.